Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
LETTERS TO THE EDITOR

Sialidase Fusion Protein as Inhibitor of Infection by Influenza Virus

Hong Zhang
Hong Zhang
Z-BioMed, Inc. Rockville, Maryland 20855
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hzhang@zbiomed.com
DOI: 10.1128/AAC.00967-08
  • Article
  • Info & Metrics
  • PDF
Loading

Malakhov et al. reported that sialidase fusion protein could be used as a novel broad-spectrum inhibitor of influenza virus infection (2). They showed a 90% effective concentration (nM) of 6.5 ± 86.8 in Table 1 as the concentration of DAS181 that gave rise to 90% cell protection from influenza virus A/Victoria/504/2000 infection (2). However, it is extremely unusual for three positive numbers with an average of 6.5 to have a standard deviation of 86.8, suggesting that the standard deviation may be a typographical error. The authors should explain this oddity.

Malakhov et al. mentioned in the abstract of their paper that “mouse and ferret studies confirmed significant in vivo efficacy of the sialidase fusion in both prophylactic and treatment modes.” In my opinion, the ferret studies presented in Table 6 of the paper do not really support that statement. Comparing the mean values of virus titers (log10 50% tissue culture infective dose/ml) between vehicle-treated ferrets and sialidase fusion protein-treated ferrets on day 1 (4.4 versus 2.4), day 2 (4.7 versus 4.6), day 3 (2.7 versus 3.9), day 4 (3.7 versus 3.4), and day 5 (negative value versus 2.6) postinfection, it is hard for readers to understand how Malakhov et al. could make the conclusion that differences between these two groups are significant. Furthermore, Malakhov et al. ignored the fact that in the group treated with the sialidase fusion protein, 7 of 12 ferrets shed virus on days 2 and 3 postchallenge, and 6 of 12 ferrets shed virus on day 4 postchallenge. More importantly, 2 of 12 ferrets in the group treated with the sialidase fusion protein still shed virus on day 5 postchallenge, while none of the 8 ferrets in the vehicle-treated group shed virus. Malakhov et al. also didn't mention that nasal virus titers in the sialidase fusion protein-treated ferrets were about 15 times higher on day 3 and at least 200 times higher on day 5 postchallenge than those in the vehicle-treated ferrets. Malakhov et al. should explain why 2 of 12 sialidase fusion protein-treated ferrets shed virus on day 5 postchallenge while none of the 8 vehicle-treated ferrets did and repeat the ferret studies before making conclusive statements. Nevertheless, Malakhov et al. did realize and describe the limitations of the ferret study in the Discussion section.

Additionally, Malakhov et al. omitted the chapter title, page numbers, and names of the editors for their reference 12, which makes it difficult for readers to find the cited reference. Therefore, I list here the complete information for that reference (1).

  • Copyright © 2009 American Society for Microbiology

REFERENCES

  1. 1.↵
    Gottschalk, A. 1959. Chemistry of virus receptors, p. 51-61. In F. M. Burnet and W. M. Stanley (ed.), The viruses: biochemical, biological, and biophysical properties. Academic Press, Inc., New York, NY.
  2. 2.↵
    Malakhov, M. P., L. M. Aschenbrenner, D. F. Smee, M. K. Wandersee, R. W. Sidwell, L. V. Gubareva, V. P. Mishin, F. G. Hayden, D. H. Kim, A. Ing, E. R. Campbell, M. Yu, and F. Fang. 2006. Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrob. Agents Chemother.50:1470-1479.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Sialidase Fusion Protein as Inhibitor of Infection by Influenza Virus
Hong Zhang
Antimicrobial Agents and Chemotherapy Feb 2009, 53 (3) 1297; DOI: 10.1128/AAC.00967-08

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sialidase Fusion Protein as Inhibitor of Infection by Influenza Virus
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Sialidase Fusion Protein as Inhibitor of Infection by Influenza Virus
Hong Zhang
Antimicrobial Agents and Chemotherapy Feb 2009, 53 (3) 1297; DOI: 10.1128/AAC.00967-08
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • REFERENCES
  • Info & Metrics
  • PDF

KEYWORDS

bacterial infections
Influenza, Human
Neuraminidase
Orthomyxoviridae

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596